4 Results for "

DoHH2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DoHH2" in MCE Product Catalog:

Cat. No.: HY-172590
LZ-07 is a selective IRAK4 PROTAC degrader with DC50 values of 1.14 nM (DOHH2) and 2.70 nM (TMD8). LZ-07 acts as a PI3Kδ kinase inhibitor with an IC50 of 92 nM. By bridging IRAK4 and the CRBN E3 ubiquitin ligase, LZ-07 induces IRAK4 degradation via the ubiquitin-proteasome system, ablates both its kinase and scaffold functions, and thereby blocks downstream inflammatory signal transduction. LZ-07 can be used in research related to autoimmune diseases .
loading...
    loading...
Cat. No.: HY-172217
CAS No.: 2982511-19-1
Research Areas:  

Cancer

DNMT1-IN-5 (Compound 55) is the inhibitor for DNMT that inhibits DNMT1 and DNMT3A with IC50 of 2.42 μM and 14.4 μM. DNMT1-IN-5 exhibits antiproliferative activity in a variety of cancer cell lines (IC50s for TMD-8, DOHH2, MOLM-13, THP-1, RPIM-8226 and HCT116 are 0.19-2.37 μM), arrests the cell cycle at G2/M phase, and induces apoptosis in TMD-8 and DOHH2 cells. DNMT1-IN-5 exhibits antitumor efficacy in TMD-8 xenograft mouse models .
loading...
    loading...
Cat. No.: HY-169307
CAS No.: 2758410-51-2
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-38 (Example 125) is a potent BTK inhibitor. BTK-IN-38 inhibits DOHH2 and BT474 cells proliferation with IC50s of 114 and 340 nM, respectively .
loading...
    loading...
Cat. No.: HY-153705
CAS No.: 2562351-92-0
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-25 (compound 71) is a potent inhibitor of BTK, and inhibits BTK(C481S) with an IC50 value of 0.77 nM. BTK-IN-25 inhibits BTK in DOHH2 cells with an IC50 value of 1 nM .
loading...
    loading...